CoChat

A circulating extracellular vesicles‐based novel screening tool for colorectal cancer revealed by shotgun and data‐independent acquisition mass spectrometry

Open access
Zheng, Xi, Xu, Kailun, Zhou, Biting, Chen, Ting, Huang, Yanqin, Li, Qilong, Wen, Fei, Ge, Weiting, Wang, Jian, Yu, Shaojun, Sun, Lifeng, Zhu, Liang, Liu, Wei, Gao, Huanhuan, Yue, Liang, Cai, Xue, Zhang, Qiushi, Ruan, Guan, Zhu, Tiansheng, Wu, Zhicheng, Zhu, Yi, Shao, Yingkuan, Guo, Tiannan, Zheng, Shu · 2020 · Journal of Extracellular Vesicles
Cited by 148

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Abstract

Background: Early screening for colorectal cancer (CRC) is essential to improve its prognosis. Liquid biopsies are increasingly being considered for diagnosing cancer due to low invasiveness and high reproducibility. In addition, circulating extracellular vesicles (crEVs, extracellular vesicles isolated from plasma) expressing tumour‐specific proteins are potential biomarkers for various cancers. Here, we present a data‐independent acquisition (DIA)‐mass spectrometry (MS)‐based diagnostic method for liquid biopsies. Methods: Extracellular vesicles (EVs) were isolated from culture supernatants of human CRC cell lines, and plasma of patients with CRC at different tumour stages, by overnight ultracentrifugation coupled with sucrose density gradient centrifugation. Tumour‐specific EV proteins were prioritized using Tandem Mass Tag (TMT)‐based shotgun proteomics and phosphoproteomics. The results were verified in a second independent cohort and a mouse tumour‐bearing model using Western blotting (WB). The candidate biomarkers were further validated in a third cohort by DIA‐MS. Finally, the DIA‐MS methodology was accelerated to permit high‐throughput detection of EV biomarkers in another independent cohort of patients with CRC and healthy controls. Results: High levels of total and phosphorylated fibronectin 1 (FN1) in crEVs, haptoglobin (HP), S100A9 and fibrinogen α chain (FGA) were significantly associated with cancer progression. FGA was the most dominant biomarker candidate. Analysis of the human CRC cell lines and the mouse model indicated that FGA+ crEVs were likely released by CRC cells. Furthermore, fast DIA‐MS and parallel reaction monitoring (PRM)‐MS both confirmed that FGA+ crEVs could distinguish colon adenoma with an area of curve (AUC) in the receiver operating characteristic (ROC) curve of 0.949 and patients with CRC (AUC of ROC is 1.000) from healthy individuals. The performance outperformed conventional tumour biomarkers. The DIA‐MS quantification of FGA+ crEVs among three groups agreed with that from PRM‐MS. Conclusion: DIA‐MS detection of FGA+ crEVs is a potential rapid and non‐invasive screening tool to identify early stage CRC. Abbreviations: FGA: fibrinogen α chain; CRC: colorectal cancer; crEVs: circulating extracellular vesicles; EV: extracellular vesicles;MS: mass spectrometry; WB: Western blotting; ROC: receiver operating characteristic; PRM: Parallel Reaction Monitoring; GPC1: Glypican‐1; GO: Gene ontology; TEM: transmission electron microscopy; FN1: Fibronectin 1; HP: haptoglobin; TMT: Tandem Mass Tag; LC‐MS/MS: liquid chromatography coupled to tandem mass spectrometry; DIA: data‐independent acquisition; DDA: data‐dependent acquisition; CiRT: Common internal Retention Time standards;AGC: Automatic gain control; AUC: area under curve.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1080/20013078.2020.1750202

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 10 references

Cited by

See all 148

Metadata

Authors
Zheng, X., Xu, K., Zhou, B., Chen, T., Huang, Y., Li, Q., Wen, F., Ge, W., Wang, J., Yu, S., Sun, L., Zhu, L., Liu, W., Gao, H., Yue, L., Cai, X., Zhang, Q., Ruan, G., Zhu, T., Wu, Z., Zhu, Y., Shao, Y., Guo, T., & Zheng, S.
Venue
Journal of Extracellular Vesicles
Publisher
Wiley
Published
2020-04-14
Volume
9
Issue
1
Pages
1750202-1750202
ISSN
2001-3078 (ISSN-L)
OpenAlex
W3017030326
Cited by
148
References
10
FWCI
6.64
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A circulating extracellular vesicles‐based novel screening tool for colorectal cancer revealed by shotgun and data‐independent acquisition mass spectrometry. https://app.cochat.ai/papers/10.1080/20013078.2020.1750202
The paper
Zheng, X., Xu, K., Zhou, B., Chen, T., Huang, Y., Li, Q., Wen, F., Ge, W., Wang, J., Yu, S., Sun, L., Zhu, L., Liu, W., Gao, H., Yue, L., Cai, X., Zhang, Q., Ruan, G., Zhu, T., . . . Zheng, S. (2020). A circulating extracellular vesicles‐based novel screening tool for colorectal cancer revealed by shotgun and data‐independent acquisition mass spectrometry. Journal of Extracellular Vesicles. https://doi.org/10.1080/20013078.2020.1750202

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.